Skip to search formSkip to main contentSkip to account menu

CB-154

Known as: CB 154, CB154 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1982
Highly Cited
1982
The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows… 
Highly Cited
1981
Highly Cited
1981
PRL involvement in periparturient mammary development and onset of milk secretion was studied in 17 multiparous, monotocous… 
1979
1979
lypophysectomized adult male rats with a pituitary transplant under the kidney capsule were used to study the effects of chronic… 
Highly Cited
1975
Highly Cited
1975
Highly Cited
1974
Highly Cited
1974
ABSTRACT A single oral dose of 2–Br–α–ergocryptine (CB154) lowers considerably plasma GH levels in 7 acromegalic patients. The… 
Highly Cited
1974
Highly Cited
1974
ABSTRACT Nine female patients with galactorrhea were selected for treatment with Bromocriptin® (CB-154), a specific inhibitor of… 
Highly Cited
1972
Highly Cited
1972
ABSTRACT A single dose of 2 Bro-α-ergocryptine (CB-154) lowers serum prolactin for at least 12 hrs. in normal subjects. CB-154 in…